Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
778.50    -6.00 (-0.76%)
Bid:
778.00
Ask:
779.00
Spread: 1.00 (0.129%)
Market Cap: £2.62b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

2 Jun 2025 14:55

RNS Number : 0744L
Drax Group PLC
02 June 2025
 

2 June 2025

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 28 February 2025, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 to purchase ordinary shares of 11 16/29 pence each in the Company (the "Programme"), it was commencing the third tranche of the Programme up to a maximum consideration of £75 million (the "Third Tranche"). As at 30 May 2025, the Company had repurchased a total of 36,102,728 shares for a consideration of c.£225 million in aggregate across the First, Second and Third Tranches.

 

The Company is today confirming that the fourth tranche of the Programme to purchase ordinary shares in the Company up to a maximum consideration of £75 million (the "Fourth Tranche") will now commence, following the conclusion of the Third Tranche on 30 May 2025.

 

The purpose of the Fourth Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Fourth Tranche will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the Fourth Tranche of the Programme is 33,469,342 being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 1 May 2025 less the shares acquired under the Third Tranche since 1 May 2025.

 

The programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc"), pursuant to which JPMS plc shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company. JPMS plc will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company.

 

This arrangement is in accordance with Chapter 9 of the United Kingdom Financial Conduct Authority Listing Rules and the Company's general authority to repurchase shares.

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcements on 7 August 2024, 22 October 2024 and 28 February 2025 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Chris Mostyn

+44 (0) 7743 963 483

 

J.P. Morgan

Robert Constant / Alia Malik

+44 (0) 20 3493 8000

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGGVFZZGKZM
Date   Source Headline
19th May 20255:37 pmRNSTransaction in Own Shares
16th May 20256:20 pmRNSTransaction in Own Shares
15th May 20255:21 pmRNSTransaction in Own Shares
15th May 202512:06 pmRNSHolding(s) in Company
14th May 20255:30 pmRNSTransaction in Own Shares
13th May 20255:34 pmRNSTransaction in Own Shares
12th May 20255:30 pmRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
8th May 20255:40 pmRNSTransaction in Own Shares
7th May 20255:40 pmRNSTransaction in Own Shares
6th May 20255:38 pmRNSTransaction in Own Shares
2nd May 20255:26 pmRNSTransaction in Own Shares
1st May 20255:36 pmRNSTransaction in Own Shares
1st May 20253:21 pmRNSTotal Voting Rights
1st May 20252:49 pmRNSNotice of change to director details
1st May 202512:40 pmRNSResult of AGM
1st May 20257:00 amRNSTrading Update
30th Apr 20255:57 pmRNSTransaction in Own Shares
29th Apr 20255:57 pmRNSTransaction in Own Shares
29th Apr 202511:42 amRNSRule 2.10 - Schroder & Co Ltd
28th Apr 20256:11 pmRNSTransaction in Own Shares
25th Apr 20255:25 pmRNSTransaction in Own Shares
24th Apr 20256:03 pmRNSTransaction in Own Shares
23rd Apr 20255:34 pmRNSTransaction in Own Shares
23rd Apr 20252:54 pmRNSNotice of change of AGM venue
22nd Apr 20255:37 pmRNSTransaction in Own Shares
17th Apr 20255:41 pmRNSTransaction in Own Shares
16th Apr 20256:01 pmRNSTransaction in Own Shares
15th Apr 20255:36 pmRNSTransaction in Own Shares
15th Apr 20254:40 pmRNSDirector/PDMR Shareholding
11th Apr 20255:45 pmRNSTransaction in Own Shares
10th Apr 20258:45 amRNSAdditional Listing
9th Apr 20255:27 pmRNSTransaction in Own Shares
8th Apr 20255:55 pmRNSTransaction in Own Shares
7th Apr 20255:39 pmRNSTransaction in Own Shares
4th Apr 20256:00 pmRNSTransaction in Own Shares
3rd Apr 20256:08 pmRNSTransaction in Own Shares
2nd Apr 20255:34 pmRNSTransaction in Own Shares
1st Apr 20255:36 pmRNSTransaction in Own Shares
1st Apr 20253:42 pmRNSTotal Voting Rights
1st Apr 202510:18 amRNSBlock listing Interim Review
1st Apr 202510:17 amRNSBlock listing Interim Review
1st Apr 202510:16 amRNSBlock listing Interim Review
1st Apr 202510:14 amRNSBlock listing Interim Review
31st Mar 20255:35 pmRNSTransaction in Own Shares
28th Mar 20256:08 pmRNSTransaction in Own Shares
28th Mar 20258:00 amRNSMailing of Annual Report and Notice of AGM
27th Mar 20255:44 pmRNSTransaction in Own Shares
27th Mar 202510:45 amRNSHolding(s) in Company
27th Mar 20257:00 amRNSJV and sale of ash to low-carbon cement industry

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.